FDA Orders New Studies on Surgical Mesh Implants
An increase in the number of complications from the use of surgical mesh implants has caused the U.S. Food and Drug Administration (FDA) to order new safety studies to be conducted on these medical devices. Between 2008 and 2010, the FDA received more than 1,500 complaints from women who suffered injuries as a result of the placement of surgical mesh implants. Reuters reported that the FDA may also place these devices in a higher risk category which would require clinical trials to be conducted.
These implants have been widely used in women to resolve issues with pelvic organ prolapse (POP) which is condition that happens when the tissue that supports the pelvic organs is weakened and allows the organs to protrude into the vagina. This mesh has also been used to treat stress urinary incontinence, also called overactive bladder.
If you or a loved one is experiencing side effects from the placement of a surgical mesh transplant, pleasecontact Cohen & Malad, LLP to speak with one of our experienced product liability/personal injury attorneys to discuss your legal options and seek the compensation you deserve.
